Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Institutional Investor > Arch Venture Corp > Profile

Instuitional Investor - Arch Venture Corp

Profile
13F Holdings

Fund Profile

Filing Period:

Fund Name:	Arch Venture Corp
Portfolio Value	$492,363,653

Top 13F Holdings

Filing Period:

No.	Security	Ticker	Shares	Value	% Port
1.	Rapport Therapeutics Inc.	RAPP	3,728,738	$110,743,519	22.49%
2.	Beam Therapeutics Inc.	BEAM	4,540,132	$110,189,004	22.38%
3.	Maze Therapeutics Inc.	MAZE	4,120,053	$106,832,974	21.7%
4.	Vir Biotechnology Inc.	VIR	12,916,663	$73,754,146	14.98%
5.	Lyell Immunopharma Inc.	LYEL	2,759,072	$44,807,329	9.1%